Liquidia Corp. (LQDA)
41.40
+1.28
(+3.19%)
USD |
NASDAQ |
Apr 16, 16:00
41.39
-0.01
(-0.02%)
After-Hours: 20:00
Liquidia Cash from Investing (Quarterly) : -4.038M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | -1.403M |
| ADMA Biologics, Inc. | -0.276M |
| Indivior Pharmaceuticals, Inc. | -22.46M |
| Lexicon Pharmaceuticals, Inc. | 4.83M |
| aTyr Pharma, Inc. | 16.44M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 44.24M |
| Cash from Financing (Quarterly) | -7.022M |
| Free Cash Flow | -40.02M |
| Free Cash Flow Per Share (Quarterly) | 0.4218 |
| Free Cash Flow to Equity (Quarterly) | 43.46M |
| Free Cash Flow to Firm (Quarterly) | 49.10M |
| Free Cash Flow Yield | -1.08% |